You are viewing an older, archived article. There may be more up to date articles on this subject, try a new search

Polypharmacy

Background, Goal and Objectives Polypharmacy PDF
Polypharmacy - weighing up the benefits and harms
Elderly people are at increased risk of drug related problems
Drugs associated with increased risk of adverse drug reactions in elderly people
Common drug interactions in elderly people
Recognising adverse drug reactions
Risk factors for drug related problems in elderly people
A really good recipe for DRP
Drug related harm; terms and definitions
Hospital admissions for adverse drug reactions
Commonly reported adverse drug reactions
References, Bibliography

References

Bjerrum L, J. Sogaard, J. Hallas, J. Kragstrup. Polypharmacy: correlations with sex, age and drug regimen, Eur J Clin Pharmacol. 1998;54(3):197–202.

Fulton MM, Allen ER. Polypharmacy in the elderly: A Literature Review. J Amer Acad Nurse Pract. 2005;17(4):123-131.

Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995;155:1949-1956.

Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical implications. Br J Clin Pharmacol. 2003;57(1):6-14.

Hanlon JT, Schmader KE, Kornkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc. 1997;45:945-948.

Hanlon JT, Lindblad CI, Gray SL. Can clinical pharmacy services have a positive impact on drug related problems and health outcomes in community based older adults ? Am J Geriatr Pharmacother. 2004;2:3-13.

Mant, J., McManus, J., & Hare, R. (2006). Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study. BMJ, 332, 635-637.

Winterstein AG, Sauer BC, Hepler CD, et al. Preventable drug-related hospital admissions. Ann Pharmacother. 2002;36:1238–48.

Bibliography

Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-1832.

bpacnz: Best Practice Advocacy Centre, (2006). ACE inhibitors. Available from http://www.bpac.org.nz/resources/campaign/ace/bpac_ace_poem_2006_wv.pdf (Accessed May 2006).

Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med. 1997;157:2089-2096.

Davis P, Lay-Yee R, Briant R et al. Adverse events in New Zealand Public Hospitals I: occurrence and impact. NZ Med J. 2002:115(1167). Available from: http://www.nzma.org.nz/journal/115-1167/271/ (Accessed April 2006).

Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Arch Intern Med. 2003;163:2716-2724.

Hepler CD, Strand LM. Opportunities and Responsibilities in Pharmaceutical Care. Am J Hosp Pharm. 1990; 47:533-43.

Hoechst Marion Roussel NZ Ltd. Rulide ™ product information. March 1996. http://www.medsafe.govt.nz/profs/Datasheet/r/Rulidetab.htm.

Kelly WN. First do no harm: Reducing medication errors in long-term care. Ann Long-Term Care 2002; 10: 49-56.

Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality; A population based study of the very old. Drugs Aging. 2005;22(1):69-82.

Medicines and Older People, 2001. National Service Framework: Dept. of Health (UK). Available from: http://www.dh.gov.uk/assetRoot/04/06/72/47/04067247.pdf (Accessed April 2006).

Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events; A clinician’s guide to terminology, documentation and reporting. Ann Intern Med 2004;140:795-801.

NPS News; 2004 No 34. National Prescribing Service Limited, Canberra, Australia. Available from: http://www.nps.org.au/site.php?content=/html/news.php&news=/resources/NPS_News/news34 (Accessed March 2006).

Prescribing for the older person. MeReC Bulletin. 2000; 11(10): 37. Available from: http://www.npc.co.uk/ebt/merec/other_non_clinical/resources/merec_bulletin_vol11_no10.pdf (Accessed April 2006).

Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997; 315: 1096- 9.

Room for Review. A guide to medication review: Medicines Partnership. (updated 31/03/2006) Available from: www.npc.co.uk.

Savage R and Tatley M. Myopathy with statins: check CK levels and interactions. Prescriber Update 2004;25(1):4-5.

Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community residing older persons. Arch Intern Med. 1994;154:2195-2200.

Ziere G, Dieleman JP, Hofman A, Pols HAP, van der Cammen TJM, Stricker BH CH. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2005;61(2):218-223.


Page  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 Page 12